[1] Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial[J]. Lancet, 2018, 391: 1163-1173. [2] Xu X, Hou J, Lv J, et al. Overexpression of lncRNA GAS5 suppresses prostatic epithelial cell proliferation by regulating COX-2 in chronic non-bacterial prostatitis[J]. Cell Cycle, 2019, 18: 923-931. [3] Ding L, Ren J, Zhang D, et al. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleu-kin-33[J]. Carcinogenesis, 2018, 39: 397-406. [4] Dong L, Ding H, Li Y, et al. LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer[J]. Cancer Manag Res, 2018, 10: 2799-2807. [5] Zhu ZJ, He JK. TINCR facilitates non-small cell lung cancer progression through BRAF-activated MAPK path-way[J]. Biochem Biophys Res Commun, 2018, 497: 971-977. [6] Tian F, Xu J, Xue F. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.[J]. Biosci Rep, 2017, 37:1-10. [7] 张传海, 桂阳, 郭凤林, 等. microRNA-7对人肝癌细胞MHCC-97H上皮间质转化的影响及作用机制[J]. 安徽医科大学学报, 2018,53:29-34. [8] Zhang Q, Li X, Li X, et al. LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells[J]. J Cell Biochem, 2018, 119: 4447-4457. [9] Yang Y, Li X, Du J, et al. Involvement of microRNAs-MMPs-E-cadherin in the migration and invasion of gastric cancer cells infected with Helicobacter pylori[J]. Exp Cell Res, 2018, 367: 196-204. [10] Conrad C, Götte M, Schlomann U, et al. ADAM8 expression in breast cancer derived brain metastases: functional implications on MMP-9 expression and transendothelial migration in breast cancer cells[J]. Int J Cancer, 2018, 142: 779-791. [11] Li F, Zhang J, Guo J, et al. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression[J]. Acta Biochim Biophys Sin (Shanghai), 2018, 50: 676-684. [12] LJeleniewicz W, Cybulski M, Nowakowski A, et al. MMP-2 mRNA expression in ovarian cancer tissues predicts patients' response to platinum-taxane chemother-apy[J]. Anticancer Res, 2019, 39: 1821-1827. [13] Zhu X, Li H, Wu Y, et al. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression[J]. Int J Mol Med, 2019, 43: 345-357. |